Compositions useful as inhibitors of protein kinases

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S118000, C544S236000, C514S233200

Reexamination Certificate

active

10738956

ABSTRACT:
The present invention provides a compound of formula (I):or a pharmaceutically acceptable salt thereof. These compounds are inhibitors of protein kinases, particularly inhibitors of PIM-1, CDK-2, GSK-3, and SRC mammalian protein kinases. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of utilizing those compounds and compositions in the treatment of various protein kinase mediated disorders.

REFERENCES:
patent: 3948912 (1976-04-01), Berger et al.
patent: 6255305 (2001-07-01), Broughton et al.
patent: 2 215 999 (1973-10-01), None
patent: 2 254 783 (1974-05-01), None
patent: 2254783 (1974-05-01), None
patent: 2 261 693 (1974-06-01), None
patent: 2 261 735 (1974-06-01), None
patent: 100 38 019 (2002-02-01), None
patent: WO99/67245 (1999-12-01), None
patent: WO 02/083139 (2002-10-01), None
patent: WO 02/083675 (2002-10-01), None
patent: WO 03/074525 (2003-09-01), None
Francavilla et al. Journal of Heterocyclic Chemistry (1971), 8(3), 415-419.
Pollack et al. Tetrahedron 1966, vol. 22, pp. 2073-2079.
Legraverend et al. Journal of Heterocyclic Chemistry (1981), 18(5), 893-898.
STN search printout (4 pages).
Bratu{hacek over (s)}k et al., “Synthesis and Reactivity of (Z)-3-benzoylamino-4-dimethylamino-2-oxo-3-butene. Preparation of 1-aryl- and 1-heteroaryl-substituted 4-benzoylamino-5-methyl-1H-pyrazoles”, Heterocycles, vol. 57, No. 11, pp. 2045-2064, (2002).
Bratu{hacek over (s)}k et al., “Transformation of 4-(1-Dimethylaminoethylidene)-2-phenyl-5(4H)-oxazolone into Methyl 2-Benzoylamino-3-oxobutanoate. The Synthesis of 1-Substituted 4-Benzoylamino-3-methyl-5(2H)-pyrazolones”, J. Het. Chem., vol. 35, pp. 1281-1284, (1998).
Parravicini, et al., “Derivati Della 3-idrazinopiridazina”, Nota II Farmaco, vol. 34., No. 4, pp. 299-310, (1979).
Vrani{hacek over (c)}ar et al., “2H-Pyran-2-ones as Synthons for (E)-α,β-Didehydroamino Acid Derivatives”, Tetrahedron, vol. 55, pp. 271-278, (1999).
Pollak et al., “Synthesis of Pyridazine Derivatives-V1Formation of s-Triazolo-(4,3-b)-pyridazines and BIS-s-Triazolo-(4,3-b,3′,4′-f)-pyridazines”, Tetrahedron, vol. 22, pp. 2073-2079, (1966).
Langof et al., “Pyridazines. LXXV. Some Quaternary and Mesoionic s-Triazolo(4,3-b)pyridazines”, Croatica Chemica Acta, vol. 47, No. 2, pp. 153-157, (1975).
Pollak et al., “Synthesis of Pyridazine Derivatives XXII. s-Triazolo[4,3-b]pyridazine 5-Oxides”, J. Het. Chem., vol. 5, No. 4, pp. 513-516, (1968).
Bregar et al., “Pyridazines, LXXXVI Some Mesoionic Mercaptoazolopyridazines”, Z. Naturforsch., vol. 31, pp. 1387-1390, (1976).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Compositions useful as inhibitors of protein kinases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions useful as inhibitors of protein kinases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions useful as inhibitors of protein kinases will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3798182

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.